Gut-Brain Axis Therapeutics, Inc.
PrivateLast Round
Series A
Nov 6, 2025
Total Funding Raised
$6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gut-Brain Axis Therapeutics, Inc. is a biotechnology company that develops microbiota transplant therapies aimed at treating gastrointestinal disorders and symptoms associated with autism and Pitt-Hopkins syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gut-Brain Axis Therapeutics, Inc. Comparables
Compare Gut-Brain Axis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Holobiome | 81% | |
| Bloom Science | 78% | |
| Genome & Company | 78% |
Gut-Brain Axis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 6, 2025 | ||||
| Seed | Dec 20, 2024 |
Gut-Brain Axis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 97% MoM.
- Feb 14, 2026
Grew 400% QoQ from 1 to 5 employees.
Gut-Brain Axis Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gut-Brain Axis Therapeutics, Inc.'s valuation, stock price, and market status.
Is Gut-Brain Axis Therapeutics, Inc. a public or private company?
Gut-Brain Axis Therapeutics, Inc. is a private company.
What is the current stock price of Gut-Brain Axis Therapeutics, Inc.?
Gut-Brain Axis Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Gut-Brain Axis Therapeutics, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Gut-Brain Axis Therapeutics, Inc. worth (valuation)?
Valuation information for Gut-Brain Axis Therapeutics, Inc. is not publicly available.
Can I buy Gut-Brain Axis Therapeutics, Inc. stock?
Gut-Brain Axis Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gut-Brain Axis Therapeutics, Inc.'s last funding round?
Gut-Brain Axis Therapeutics, Inc.'s most recent funding round was Series A on November 6, 2025.
Who are the main investors in Gut-Brain Axis Therapeutics, Inc.?
Key investors in Gut-Brain Axis Therapeutics, Inc. include HealthTech Capital.
Will Gut-Brain Axis Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Gut-Brain Axis Therapeutics, Inc..
How can I track Gut-Brain Axis Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gut-Brain Axis Therapeutics, Inc.'s secondary market activity and sign up for updates.